Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
基本信息
- 批准号:10531921
- 负责人:
- 金额:$ 65.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAllelesAttenuatedAutophagocytosisAutophagolysosomeBacillusBacteriaBacterial InfectionsCause of DeathCellsCollaborationsDataDoseGenerationsGoalsGrowthHumanImmuneImmune EvasionImmunityImpairmentInfectionInfection ControlInnate Immune ResponseInnovative TherapyKnockout MiceLipidsLungLysosomesMacrophageMediatorMicrobeMitochondriaModelingMusMycobacterium tuberculosisMyeloid CellsNADPNADPH OxidaseOxidasesPathway interactionsPersonsPhagocytosisPhagolysosomePhagosomesPhospholipase DPlayProductionPropertyProtein Export PathwayProtein SecretionProteinsReactive InhibitionReactive Oxygen SpeciesRoleSiteSystemTestingTetracyclinesTuberculosisTuberculosis VaccinesVaccinesVirulenceVirulence FactorsWorkacute infectionantimicrobialblocking factorcell typechronic infectionconditional knockoutimprovedin vivoinnate immune functioninnate immune mechanismsinnovationinsightmutantmycobacterialneutrophilnovel strategiespathogenpreventrecruittraffickingtuberculosis treatment
项目摘要
SUMMARY
The goal of this project is to understand how two virulence factors from Mycobacterium tuberculosis (Mtb), CpsA
and phthiocerol dimycocerosate (PDIM), impair immunity by undermining both classical and non-classical
autophagy. Mtb is the causative agent of tuberculosis (TB), the leading cause of death worldwide from a bacterial
infection. The main cellular niche for Mtb is macrophages and neutrophils, the very immune cells that are meant
to clear infection. How Mtb survives the innate immune response to establish infection is not well understood. In
the previous project period, we discovered that an exported protein, CpsA, is critically important for Mtb virulence.
We showed that CpsA inhibits phagosomal recruitment of the NADPH oxidase. The NADPH oxidase makes
reactive oxygen species (ROS), an important mediator of the innate immune response. In addition to its direct
antimicrobial activity, ROS is required for a lysosomal trafficking pathway called LC3-associated phagocytosis
(LAP), a non-classical form of autophagy. Thus, by inhibiting ROS, CpsA also inhibits LAP. We showed both in
macrophages and mice that CpsA protects Mtb from the NADPH oxidase and LAP. Interestingly, CpsA physically
interacts NDP52 and TAX1BP1, autophagy adaptors that function in a form of classical autophagy (xenophagy),
suggesting that CpsA may also impair xenophagy. Moreover, we found that the Mtb virulence lipid, PDIM, also
inhibits the NADPH oxidase. Previous studies proposed an array of roles for PDIM and showed that it protects
Mtb from a poorly defined innate killing mechanism. Our data suggest that an unappreciated virulence property
of PDIM is blocking the NADPH oxidase and LAP. Thus, we hypothesize that CpsA inhibits xenophagy and
works in concert with PDIM to inhibit the NADPH oxidase and LAP. Further, we propose that the infectious dose
of Mtb depends upon its ability to evade these innate defenses in myeloid cells that are recruited to the lungs
during initial infection. Here, we will define how CpsA inhibits the NADPH oxidase and investigate whether it also
impairs xenophagy by blocking NDP52 and TAX1BP1 function. We will determine whether PDIM also impairs
recruitment of the NADPH oxidase to mycobacterial phagosomes and evaluate the contribution that PDIM plays
towards subverting the NADPH oxidase and LAP in vivo. To determine whether CpsA promotes the
establishment of infection, we will use an ultra-low dose infection model in mice. Using conditional knockout
(cKO) mice, we will determine in which cells CpsA functions to inhibit the NADPH oxidase and LAP during acute
and chronic infection. Our findings will provide mechanistic insight into how two key virulence factors in Mtb
collaborate to undermine immunity. Our studies will reveal a cell type-specific virulence strategy of the bacilli,
delineate the cell types that participate in LAP in vivo, and define host-pathogen interactions that govern the
establishment of infection. Our studies will provide detailed mechanistic insight into the immune evasion
strategies of one of the world's most formidable pathogens. By elucidating the mechanism of action of two crucial
virulence factors in Mtb, we will advance innovative approaches to prevent and treat TB.
摘要
这个项目的目标是了解结核分枝杆菌(Mtb)的两个毒力因子CPSA是如何
和邻苯二甲酸甘油酯(PDIM),通过破坏经典和非经典的方式来损害免疫力
自噬。结核分枝杆菌是结核病(TB)的病原体,是全球范围内由细菌引起的主要死亡原因
感染。结核分枝杆菌的主要细胞生态位是巨噬细胞和中性粒细胞,也就是免疫细胞。
来清除感染。结核分枝杆菌是如何在先天免疫反应中存活下来,从而建立感染的,目前还不清楚。在……里面
在上一个项目期间,我们发现一种出口蛋白CPSA对结核分枝杆菌的毒力至关重要。
我们发现CPSA能抑制NADPH氧化酶的吞噬体募集。NADPH氧化酶使
活性氧(ROS),先天免疫反应的重要介体。除了它的直接
抗菌活性,ROS是溶酶体转运途径所必需的,称为LC3相关的吞噬作用
(LAP),一种非经典的自噬形式。因此,通过抑制ROS,CPSA也抑制了LAP。我们两个都展示在
巨噬细胞和小鼠,CPSA保护线粒体免受NADPH氧化酶和LAP的伤害。有趣的是,CPSA在身体上
与NDP52和TAX1BP1相互作用,这是一种以经典自噬(异种吞噬)的形式发挥作用的自噬适配器,
这表明CPSA也可能会损害异种吞噬作用。此外,我们还发现结核分枝杆菌毒力脂,PDIM,也
抑制NADPH氧化酶。以前的研究提出了PDIM的一系列角色,并表明它可以保护
结核分枝杆菌来自一种不明确的先天杀死机制。我们的数据表明,一种未经评估的致命性
PDIM的作用是阻断NADPH氧化酶和LAP。因此,我们假设CPSA抑制异体吞噬和
与PDIM协同工作,抑制NADPH氧化酶和LAP。此外,我们还提出,感染剂量
结核分枝杆菌的感染依赖于它逃避这些被招募到肺部的髓系细胞的先天防御的能力。
在最初的感染期间。在这里,我们将定义CPSA是如何抑制NADPH氧化酶的,并研究它是否也
通过阻断NDP52和TAX1BP1功能而损害异种吞噬功能。我们将确定PDIM是否也会损害
NADPH氧化酶在分枝杆菌噬菌体中的募集及PDIM的作用
在体内颠覆NADPH氧化酶和LAP。以确定CPSA是否促进
建立感染模型后,我们将采用超低剂量感染小鼠。使用条件淘汰法
(CKO)小鼠,我们将确定在急性发作期间,CPSA在哪些细胞中发挥抑制NADPH氧化酶和LAP的作用
和慢性感染。我们的发现将为结核分枝杆菌的两个关键毒力因素提供机械洞察
合谋破坏豁免权。我们的研究将揭示细菌特定细胞类型的毒力策略,
描述在体内参与LAP的细胞类型,并定义管理LAP的宿主-病原体相互作用
建立感染机制。我们的研究将为免疫逃避提供详细的机制洞察
世界上最可怕的病原体之一的策略。通过阐明两个关键分子的作用机制
在结核分枝杆菌的毒力因素方面,我们将推进防治结核病的创新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNIFER A PHILIPS其他文献
JENNIFER A PHILIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNIFER A PHILIPS', 18)}}的其他基金
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease
结核病发病机制中的胆固醇氧化产物及其作为疾病的生物标志物
- 批准号:
10216045 - 财政年份:2021
- 资助金额:
$ 65.65万 - 项目类别:
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease
结核病发病机制中的胆固醇氧化产物及其作为疾病的生物标志物
- 批准号:
10343850 - 财政年份:2021
- 资助金额:
$ 65.65万 - 项目类别:
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
- 批准号:
10390674 - 财政年份:2017
- 资助金额:
$ 65.65万 - 项目类别:
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
- 批准号:
10078851 - 财政年份:2017
- 资助金额:
$ 65.65万 - 项目类别:
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA
ESCRT 在巨噬细胞抵抗分枝杆菌中的作用
- 批准号:
9125720 - 财政年份:2015
- 资助金额:
$ 65.65万 - 项目类别:
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
泛素在结核病先天免疫中的作用
- 批准号:
8636559 - 财政年份:2014
- 资助金额:
$ 65.65万 - 项目类别:
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
泛素在结核病先天免疫中的作用
- 批准号:
9062959 - 财政年份:2014
- 资助金额:
$ 65.65万 - 项目类别:
The Role of ESCRT in Macrophage Resistance to Mycobacteria
ESRT 在巨噬细胞对分枝杆菌耐药中的作用
- 批准号:
8670599 - 财政年份:2013
- 资助金额:
$ 65.65万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 65.65万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 65.65万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 65.65万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 65.65万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 65.65万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 65.65万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 65.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 65.65万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 65.65万 - 项目类别:














{{item.name}}会员




